Conditions: Attention Deficit Hyperactivity Disorder
Allocation:  | Intervention model: FACTORIAL
Enrollment: 45
Healthy volunteers: no

Brief summary:
The objective is to assess overall safety and tolerability of atomoxetine in doses up to 120 mg/day in Japanese adult patients who meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for ADHD

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Atomoxetine
Intervention descriptions: intervention 1: 40 mg/day every day (QD), by mouth (PO), for 1 week; 80 mg/day every day, by mouth, for 1 week; 105 mg/day every day, by mouth, for 2 weeks; 120 mg/day every day, by mouth, for 4 weeks

Protocol document: